Marker Therapeutics's total assets for Q3 2024 were $10.91M, a decrease of -6.55% from the previous quarter. MRKR total liabilities were $3.46M for the fiscal quarter, a 75.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.